Patricia S Andrews - Net Worth and Insider Trading
Patricia S Andrews Net Worth
The estimated net worth of Patricia S Andrews is at least $7,693 dollars as of 2024-09-20. Patricia S Andrews is the Director of GlycoMimetics Inc and owns about 45,250 shares of GlycoMimetics Inc (GLYC) stock worth over $7,693. Details can be seen in Patricia S Andrews's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patricia S Andrews has not made any transactions after 2021-11-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Patricia S Andrews
Patricia S Andrews Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patricia S Andrews owns 2 companies in total, including GlycoMimetics Inc (GLYC) , and Incyte Corp (INCY) .
Click here to see the complete history of Patricia S Andrews’s form 4 insider trades.
Insider Ownership Summary of Patricia S Andrews
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GLYC | GlycoMimetics Inc | 2021-11-16 | director |
| INCY | Incyte Corp | 2008-10-21 | Chief Commercial Officer |
Patricia S Andrews Latest Holdings Summary
Patricia S Andrews currently owns a total of 1 stock. Patricia S Andrews owns 45,250 shares of GlycoMimetics Inc (GLYC) as of November 16, 2021, with a value of $7,693.
Latest Holdings of Patricia S Andrews
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GLYC | GlycoMimetics Inc | 2021-11-16 | 45,250 | 0.17 | 7,693 |
Holding Weightings of Patricia S Andrews
Patricia S Andrews Form 4 Trading Tracker
According to the SEC Form 4 filings, Patricia S Andrews has made a total of 1 transactions in GlycoMimetics Inc (GLYC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in GlycoMimetics Inc is the acquisition of 40,000 shares on November 16, 2021, which cost Patricia S Andrews around $82,000.
Insider Trading History of Patricia S Andrews
- 1
Patricia S Andrews Trading Performance
GuruFocus tracks the stock performance after each of Patricia S Andrews's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patricia S Andrews is -46.5%. GuruFocus also compares Patricia S Andrews's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patricia S Andrews within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Patricia S Andrews's insider trading performs compared to the benchmark.
Performance of Patricia S Andrews
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -22 | | | | | |
| Relative Return to S&P 500(%) | -21.31 | | | | | |
Patricia S Andrews Ownership Network
Patricia S Andrews Owned Company Details
What does GlycoMimetics Inc do?
Who are the key executives at GlycoMimetics Inc?
Patricia S Andrews is the director of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include 10 percent owner Invus Public Equities, L.p. , Chief Medical Officer Edwin Rock , and CFO Brian M. Hahn .
GlycoMimetics Inc (GLYC) Insider Trades Summary
Over the past 18 months, Patricia S Andrews made no insider transaction in GlycoMimetics Inc (GLYC). Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net sale of 2,271,499 shares made by Invus Public Equities, L.p. , a net purchase of 370,403 shares made by Edwin Rock , and a net purchase of 13,800 shares made by Brian M. Hahn .
In summary, during the past 3 months, insiders sold 2,271,499 shares of GlycoMimetics Inc (GLYC) in total and bought 305,000 shares, with a net sale of 1,966,499 shares. During the past 18 months, 2,275,199 shares of GlycoMimetics Inc (GLYC) were sold and 431,403 shares were bought by its insiders, resulting in a net sale of 1,843,796 shares.
GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.
GlycoMimetics Inc Insider Transactions
Patricia S Andrews Mailing Address
Above is the net worth, insider trading, and ownership report for Patricia S Andrews. You might contact Patricia S Andrews via mailing address: Experimental Station, Route 141 And Henry Clay Rd, Wilmington De 19880.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
